Improved Middle-Down Characterization of Antibodies Using Multiple Ion Activation Techniques and Ion-Ion Proton Transfer Reactions on a Modified Orbitrap Mass Spectrometer
Posters | 2018 | Thermo Fisher Scientific | ASMSInstrumentation
Monoclonal antibodies play a crucial role in biotherapeutics and diagnostics. Detailed sequence characterization of antibody subunits supports quality control, comparability studies, and detection of sequence variants and post-translational modifications. Middle-down mass spectrometry bridges the gap between top-down and bottom-up approaches by preserving large fragments for structural analysis.
This work evaluates the benefit of applying ion-ion proton transfer (IIPT) reactions to selected product-ion m/z windows following various fragmentation methods in a middle-down LC-MS3 workflow. The goal is to improve detection of high-mass sequence ions in the light chain (LC), Fd, and Fc/2 subunits of a NIST mAb standard.
Sample preparation included IdeS proteolysis and reduction to yield ~25 kDa subunits. Online reversed-phase LC separated subunits prior to targeted MS2 and MS3 acquisition. A modified Thermo Scientific Orbitrap Fusion Lumos Tribrid mass spectrometer featured dual reagent inlets to introduce ETD and IIPT reagents simultaneously. Fragmentation modes covered ETD, CID, HCD, and UVPD, with subsequent IIPT applied to narrow m/z windows of product ions. Data processing was performed using QualBrowser, BioPharma Finder, and ProSight Lite.
Combining ETD with IIPT (Experiments 1–5) provided the most significant increase in sequence coverage, revealing long, high-mass fragment ions across all subunits. Aggregate coverage for these experiments reached up to ~92%, with extensive mapping of complementary N- and C-terminal fragments. In contrast, IIPT following CID or HCD yielded lower coverage (13–31%) due to the use of broader m/z windows that led to spectral congestion.
- Enhanced detection of large sequence ions improves confidence in sequence assignment and PTM localization.
- Accelerated middle-down workflows support rapid comparability and QA/QC of biotherapeutic antibodies.
- The approach can be integrated into regulated laboratories for routine antibody characterization.
Applying IIPT to UVPD-generated product ions and refining m/z window widths are promising directions to further boost sequence coverage. Automation of targeted IIPT strategies and integration with advanced bioinformatics will enable higher throughput and deeper structural insights in antibody analysis.
This preliminary study demonstrates that targeted IIPT following ETD fragmentation substantially enhances middle-down sequence coverage of mAb subunits, enabling observation of large fragment ions that are otherwise obscured. Optimization of window selection and application to other activation methods will expand its utility in antibody characterization.
LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap
IndustriesPharma & Biopharma
ManufacturerThermo Fisher Scientific
Summary
Importance of the topic
Monoclonal antibodies play a crucial role in biotherapeutics and diagnostics. Detailed sequence characterization of antibody subunits supports quality control, comparability studies, and detection of sequence variants and post-translational modifications. Middle-down mass spectrometry bridges the gap between top-down and bottom-up approaches by preserving large fragments for structural analysis.
Objectives and overview of the study
This work evaluates the benefit of applying ion-ion proton transfer (IIPT) reactions to selected product-ion m/z windows following various fragmentation methods in a middle-down LC-MS3 workflow. The goal is to improve detection of high-mass sequence ions in the light chain (LC), Fd, and Fc/2 subunits of a NIST mAb standard.
Methodology and instrumentation
Sample preparation included IdeS proteolysis and reduction to yield ~25 kDa subunits. Online reversed-phase LC separated subunits prior to targeted MS2 and MS3 acquisition. A modified Thermo Scientific Orbitrap Fusion Lumos Tribrid mass spectrometer featured dual reagent inlets to introduce ETD and IIPT reagents simultaneously. Fragmentation modes covered ETD, CID, HCD, and UVPD, with subsequent IIPT applied to narrow m/z windows of product ions. Data processing was performed using QualBrowser, BioPharma Finder, and ProSight Lite.
Main results and discussion
Combining ETD with IIPT (Experiments 1–5) provided the most significant increase in sequence coverage, revealing long, high-mass fragment ions across all subunits. Aggregate coverage for these experiments reached up to ~92%, with extensive mapping of complementary N- and C-terminal fragments. In contrast, IIPT following CID or HCD yielded lower coverage (13–31%) due to the use of broader m/z windows that led to spectral congestion.
Benefits and practical applications of the method
- Enhanced detection of large sequence ions improves confidence in sequence assignment and PTM localization.
- Accelerated middle-down workflows support rapid comparability and QA/QC of biotherapeutic antibodies.
- The approach can be integrated into regulated laboratories for routine antibody characterization.
Future trends and opportunities
Applying IIPT to UVPD-generated product ions and refining m/z window widths are promising directions to further boost sequence coverage. Automation of targeted IIPT strategies and integration with advanced bioinformatics will enable higher throughput and deeper structural insights in antibody analysis.
Conclusion
This preliminary study demonstrates that targeted IIPT following ETD fragmentation substantially enhances middle-down sequence coverage of mAb subunits, enabling observation of large fragment ions that are otherwise obscured. Optimization of window selection and application to other activation methods will expand its utility in antibody characterization.
Used instrumentation
- Thermo Scientific UltiMate 3000 HPLC system with RP-4H column, flow rate 1.5 µL/min
- Modified Thermo Scientific Orbitrap Fusion Lumos Tribrid mass spectrometer with dual reagent inlet for ETD and IIPT
- Data analysis software: QualBrowser, BioPharma Finder 3.0, ProSight Lite
References
- Houel S, Fornelli L, Srzentic K, et al. Middle-down analyses of monoclonal antibodies on Orbitrap Fusion Lumos Tribrid. Proceedings of the 16th Annual HUPO World Congress; 2017.
- Anderson LC, English MA, Wang WH, et al. Protein derivatization and sequential ion/ion reactions to enhance sequence coverage by electron transfer dissociation mass spectrometry. Int J Mass Spectrom. 2015;377:717–724.
- Mullen C, Schwartz JC, Syka JEP, et al. Improved top-down sequence coverage on a Tribrid mass spectrometer by ion-ion proton transfer reactions subsequent to ETD and UVPD. ASMS 66th Conf.; San Diego, 2018.
- Sanders J, Holden D, et al. Reducing congestion in ultraviolet photodissociation spectra of large protein ions using proton transfer reactions. ASMS 66th Conf.; San Diego, 2018.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
In-depth characterization of monoclonal antibodies
2024|Thermo Fisher Scientific|Applications
Technical note | 003318 Biopharma In-depth characterization of monoclonal antibodies Intact mass analysis and middle-down mass spectrometry approaches on an Orbitrap Ascend BioPharma Tribrid mass spectrometer Authors Goal Jingjing Huang, Christopher Mullen, To assess the performance of the Thermo Scientific™…
Key words
trastuzumab, trastuzumabsubunits, subunitsintact, intactuvpd, uvpdactivation, activationtype, typeethcd, ethcdarb, arbmass, massorbitrap, orbitrapascend, ascendparameters, parametersfragmentation, fragmentationscan, scantrue
Proton transfer charge reduction (PTCR)
2021|Thermo Fisher Scientific|Applications
APPLICATION NOTE 74160 Proton transfer charge reduction (PTCR) improves spectral matching and sequence coverage in middle-down analysis of monoclonal antibodies Luca Fornelli,1 Ryan N. Oates,1 Kristina Srzentić,2 Christopher Mullen,3 John E. P. Syka,3 and Romain Huguet3 University of Oklahoma, Norman,…
Key words
ptcr, ptcretd, etdorbitrap, orbitrapproduct, production, ionmab, mabions, ionsmass, masscoverage, coveragecharge, chargesequence, sequencecomplementary, complementarymiddle, middlethermo, thermoreduction
Top-down Characterization of Monoclonal Antibody on an Orbitrap Fusion Lumos Tribrid Mass Spectrometer
2016|Thermo Fisher Scientific|Posters
Poster Note 64778 Top-down Characterization of Monoclonal Antibody on an Orbitrap Fusion Lumos™ Tribrid Mass Spectrometer Seema Sharma, Stephane Houel, Christopher Mullen, Chad Weisbrod, Romain Huguet, John Syka, Dave Horn, Jonathan Josephs, Jae Schwartz, Vlad Zabrouskov Thermo Fisher Scientific, San…
Key words
abundance, abundancefragmentation, fragmentationantibody, antibodyintact, intactetd, etdrelative, relativemab, mabtop, topdown, downheavy, heavydeglycosylated, deglycosylatedmonoclonal, monoclonaluvpd, uvpdpulses, pulsessequence
Discovery with the Orbitrap Eclipse Tribrid mass spectrometer
2021|Thermo Fisher Scientific|Technical notes
WHITE PAPER 65971 Grant application resource Go beyond today’s discovery with the Orbitrap Eclipse Tribrid mass spectrometer Keywords: Orbitrap Eclipse Tribrid Mass Spectrometer, FAIMS Pro Interface, Mass Spectrometry, Quantitative Proteomics, TMT and TMTpro Multiplexing, Single-cell Sensitivity, Top-down Proteomics, Native Intact…
Key words
orbitrap, orbitraptribrid, tribridfaims, faimseclipse, eclipsemass, masstmt, tmtion, ionprotein, proteinptcr, ptcrotit, otitsearch, searchprecursor, precursorsps, spsspectrometer, spectrometerisolation